Cognition in Huntington's Disease in Manifest, Premanifest and Converting Gene Carriers Over Ten Years

被引:9
|
作者
Hart, Ellen P. [1 ]
Dumas, Eve M. [1 ]
Giltay, Erik J. [2 ]
Middelkoop, Huub A. M. [1 ,3 ]
Roos, Raymund A. C. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands
[3] Leiden Univ, Inst Psychol, Clin Neuropsychol Unit, Leiden, Netherlands
关键词
Huntington's disease; executive functioning; longitudinal; converters; premanifest;
D O I
10.3233/JHD-130059
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Cognitive decline in Huntington's disease (HD) remains an area of inconsistencies, especially far from disease onset. Objective: To clarify the course of cognition in premanifest HD. Methods: Twenty-six premanifest HD, 19 manifest HD, and 87 control subjects were followed for ten years, using an extensive cognitive battery. Differences in baseline levels and change over time, on four factors (motor speed, global cognition, executive functioning (EF), and memory) were examined, using multilevel regression analyses. Converters were additionally analysed as a separate group. Also, the influence of motor speed and predicted years to disease onset on the cognitive factors was studied. Results: Manifest HD subjects showed lower baseline scores compared to controls on the motor speed (p = 0.002), memory (p < 0.001) and EF (p < 0.001). They additionally deteriorated over the ten-year follow-up on memory (p = 0.01). Converters deteriorated on EF (p = 0.04). Further analyses of premanifest subjects 'far from and close to predicted onset' revealed lower baseline scores for the 'close' group on EF, as compared to controls (p = 0.001). They also deteriorated on memory (p = 0.01). Motor speed substantially mediated the results of the three cognitive factors; when added as covariate to the model several baseline and slope differences for the cognitive factors ceased to be significant. Conclusions: Memory and EF are highly sensitive for ascertaining deterioration in premanifest HD gene carriers, especially in subjects close to onset. Lack of deterioration for the subjects further away from onset suggests that both domains are largely unaffected in those far from onset. Also, motor influence on cognition is substantial and should be taken into account in cognitive HD research.
引用
收藏
页码:137 / 147
页数:11
相关论文
共 50 条
  • [1] Peripheral Biomarkers in Manifest and Premanifest Huntington's Disease
    Morena, Emanuele
    Romano, Carmela
    Marconi, Martina
    Diamant, Selene
    Buscarinu, Maria Chiara
    Bellucci, Gianmarco
    Romano, Silvia
    Scarabino, Daniela
    Salvetti, Marco
    Ristori, Giovanni
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [2] Progress in Premanifest and Manifest Diagnostics in Huntington's Disease
    Saft, C.
    Kosinski, C. M.
    Landwehrmeyer, G. B.
    AKTUELLE NEUROLOGIE, 2009, 36 (10) : 506 - +
  • [3] Assessing Impairment of Executive Function and Psychomotor Speed in Premanifest and Manifest Huntington's Disease Gene-expansion Carriers
    Larsen, Ida Unmack
    Vinther-Jensen, Tua
    Gade, Anders
    Nielsen, Jorgen Erik
    Vogel, Asmus
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2015, 21 (03) : 193 - 202
  • [4] Striatal hypometabolism in premanifest and manifest Huntington's disease patients
    Alfonso Lopez-Mora, Diego
    Camacho, Valle
    Perez-Perez, Jesus
    Martinez-Horta, Saul
    Fernandez, Alejandro
    Sampedro, Frederic
    Montes, Alberto
    Andrea Lozano-Martinez, Gloria
    Gomez-Anson, Beatriz
    Kulisevsky, Jaime
    Carrio, Ignasi
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (12) : 2183 - 2189
  • [5] Striatal hypometabolism in premanifest and manifest Huntington’s disease patients
    Diego Alfonso López-Mora
    Valle Camacho
    Jesús Pérez-Pérez
    Saül Martínez-Horta
    Alejandro Fernández
    Frederic Sampedro
    Alberto Montes
    Gloria Andrea Lozano-Martínez
    Beatriz Gómez-Anson
    Jaime Kulisevsky
    Ignasi Carrió
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 2183 - 2189
  • [6] Postural Limits of Stability in Premanifest and Manifest Huntington's Disease
    Medina, Luis D.
    Pirogovsky, Eva
    Salomonczyk, Danielle
    Goldstein, Jody
    Panzera, Robert
    Gluhm, Shea
    Simmons, Roger
    Corey-Bloom, Jody
    Gilbert, Paul E.
    JOURNAL OF HUNTINGTONS DISEASE, 2013, 2 (02) : 177 - 184
  • [7] Profiling Social Cognition in Premanifest Huntington's Disease
    Turner, Kate
    Bartlett, Danielle
    Grainger, Sarah A.
    Eddy, Clare
    Reyes, Alvaro
    Kordsachia, Catarina
    Turner, Mitchell
    Stout, Julie C.
    Georgiou-Karistianis, Nellie
    Henry, Julie D.
    Ziman, Mel
    Cruickshank, Travis
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2022, 28 (03) : 217 - 229
  • [8] Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers
    Pavese, Nicola
    Politis, Marios
    Tai, Yen F.
    Barker, Roger A.
    Tabrizi, Sarah J.
    Mason, Sarah L.
    Brooks, David J.
    Piccini, Paola
    NEUROBIOLOGY OF DISEASE, 2010, 37 (02) : 356 - 361
  • [9] Progressive spinal cord atrophy in manifest and premanifest Huntington's disease
    Wilhelms, Weike
    Bellenberg, Barbara
    Koester, Odo
    Weiler, Florian
    Hoffmann, Rainer
    Gold, Ralf
    Saft, Carsten
    Lukas, Carsten
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (07): : 614 - 616
  • [10] Computerised Dynamic Posturography in Premanifest and Manifest individuals with Huntington’s Disease
    Alvaro Reyes
    Danielle Salomonczyk
    Wei-Peng Teo
    Luis D. Medina
    Danielle Bartlett
    Eva Pirogovsky-Turk
    Pauline Zaenker
    Jody Corey Bloom
    Roger W. Simmons
    Mel Ziman
    Paul E. Gilbert
    Travis Cruickshank
    Scientific Reports, 8